Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Wide-area low-energy surface stimulation of large mammalian ventricular tissue.

Moreno A, Walton RD, Constantin M, Bernus O, Vigmond EJ, Bayer JD.

Sci Rep. 2019 Nov 1;9(1):15863. doi: 10.1038/s41598-019-51364-w.

2.

Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation.

Bayer JD, Boukens BJ, Krul SPJ, Roney CH, Driessen AHG, Berger WR, van den Berg NWE, Verkerk AO, Vigmond EJ, Coronel R, de Groot JR.

Front Physiol. 2019 Sep 4;10:1105. doi: 10.3389/fphys.2019.01105. eCollection 2019.

3.

Wavelength and Fibrosis Affect Phase Singularity Locations During Atrial Fibrillation.

Saha M, Roney CH, Bayer JD, Meo M, Cochet H, Dubois R, Vigmond EJ.

Front Physiol. 2018 Sep 10;9:1207. doi: 10.3389/fphys.2018.01207. eCollection 2018.

4.

Role of the Purkinje-Muscle Junction on the Ventricular Repolarization Heterogeneity in the Healthy and Ischemic Ovine Ventricular Myocardium.

Martinez ME, Walton RD, Bayer JD, Haïssaguerre M, Vigmond EJ, Hocini M, Bernus O.

Front Physiol. 2018 Jun 14;9:718. doi: 10.3389/fphys.2018.00718. eCollection 2018.

5.

Variability in pulmonary vein electrophysiology and fibrosis determines arrhythmia susceptibility and dynamics.

Roney CH, Bayer JD, Cochet H, Meo M, Dubois R, Jaïs P, Vigmond EJ.

PLoS Comput Biol. 2018 May 24;14(5):e1006166. doi: 10.1371/journal.pcbi.1006166. eCollection 2018 May.

6.

Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.

Liu J, Bayer JD, Aschar-Sobbi R, Wauchop M, Spears D, Gollob M, Vigmond EJ, Tsushima R, Backx PH, Chauhan VS.

PLoS One. 2018 May 23;13(5):e0197273. doi: 10.1371/journal.pone.0197273. eCollection 2018.

7.

Spatial Resolution Requirements for Accurate Identification of Drivers of Atrial Fibrillation.

Roney CH, Cantwell CD, Bayer JD, Qureshi NA, Lim PB, Tweedy JH, Kanagaratnam P, Peters NS, Vigmond EJ, Ng FS.

Circ Arrhythm Electrophysiol. 2017 May;10(5):e004899. doi: 10.1161/CIRCEP.116.004899.

8.

Modelling methodology of atrial fibrosis affects rotor dynamics and electrograms.

Roney CH, Bayer JD, Zahid S, Meo M, Boyle PM, Trayanova NA, Haïssaguerre M, Dubois R, Cochet H, Vigmond EJ.

Europace. 2016 Dec;18(suppl 4):iv146-iv155. doi: 10.1093/europace/euw365.

9.

Mechanisms linking electrical alternans and clinical ventricular arrhythmia in human heart failure.

Bayer JD, Lalani GG, Vigmond EJ, Narayan SM, Trayanova NA.

Heart Rhythm. 2016 Sep;13(9):1922-31. doi: 10.1016/j.hrthm.2016.05.017. Epub 2016 May 20.

10.

Novel Radiofrequency Ablation Strategies for Terminating Atrial Fibrillation in the Left Atrium: A Simulation Study.

Bayer JD, Roney CH, Pashaei A, Jaïs P, Vigmond EJ.

Front Physiol. 2016 Apr 12;7:108. doi: 10.3389/fphys.2016.00108. eCollection 2016.

11.

Opsin spectral sensitivity determines the effectiveness of optogenetic termination of ventricular fibrillation in the human heart: a simulation study.

Karathanos TV, Bayer JD, Wang D, Boyle PM, Trayanova NA.

J Physiol. 2016 Dec 1;594(23):6879-6891. doi: 10.1113/JP271739. Epub 2016 Apr 24.

12.

Disrupted calcium release as a mechanism for atrial alternans associated with human atrial fibrillation.

Chang KC, Bayer JD, Trayanova NA.

PLoS Comput Biol. 2014 Dec 11;10(12):e1004011. doi: 10.1371/journal.pcbi.1004011. eCollection 2014 Dec.

13.

Fitting C² continuous parametric surfaces to frontiers delimiting physiologic structures.

Bayer JD, Epstein M, Beaumont J.

Comput Math Methods Med. 2014;2014:278479. doi: 10.1155/2014/278479. Epub 2014 Mar 24.

14.

Feasibility of image-based simulation to estimate ablation target in human ventricular arrhythmia.

Ashikaga H, Arevalo H, Vadakkumpadan F, Blake RC 3rd, Bayer JD, Nazarian S, Muz Zviman M, Tandri H, Berger RD, Calkins H, Herzka DA, Trayanova NA, Halperin HR.

Heart Rhythm. 2013 Aug;10(8):1109-16. doi: 10.1016/j.hrthm.2013.04.015. Epub 2013 Apr 19.

15.

Effects of mechano-electric feedback on scroll wave stability in human ventricular fibrillation.

Hu Y, Gurev V, Constantino J, Bayer JD, Trayanova NA.

PLoS One. 2013;8(4):e60287. doi: 10.1371/journal.pone.0060287. Epub 2013 Apr 3.

16.

Computational cardiology: how computer simulations could be used to develop new therapies and advance existing ones.

Trayanova NA, O'Hara T, Bayer JD, Boyle PM, McDowell KS, Constantino J, Arevalo HJ, Hu Y, Vadakkumpadan F.

Europace. 2012 Nov;14 Suppl 5:v82-v89. doi: 10.1093/europace/eus277. Review.

17.

Mechanisms of human atrial fibrillation initiation: clinical and computational studies of repolarization restitution and activation latency.

Krummen DE, Bayer JD, Ho J, Ho G, Smetak MR, Clopton P, Trayanova NA, Narayan SM.

Circ Arrhythm Electrophysiol. 2012 Dec;5(6):1149-59. doi: 10.1161/CIRCEP.111.969022. Epub 2012 Oct 1.

18.

A novel rule-based algorithm for assigning myocardial fiber orientation to computational heart models.

Bayer JD, Blake RC, Plank G, Trayanova NA.

Ann Biomed Eng. 2012 Oct;40(10):2243-54. doi: 10.1007/s10439-012-0593-5. Epub 2012 May 31.

19.

A computational model to predict the effects of class I anti-arrhythmic drugs on ventricular rhythms.

Moreno JD, Zhu ZI, Yang PC, Bankston JR, Jeng MT, Kang C, Wang L, Bayer JD, Christini DJ, Trayanova NA, Ripplinger CM, Kass RS, Clancy CE.

Sci Transl Med. 2011 Aug 31;3(98):98ra83. doi: 10.1126/scitranslmed.3002588.

20.

Rate-dependent action potential alternans in human heart failure implicates abnormal intracellular calcium handling.

Bayer JD, Narayan SM, Lalani GG, Trayanova NA.

Heart Rhythm. 2010 Aug;7(8):1093-101. doi: 10.1016/j.hrthm.2010.04.008. Epub 2010 Apr 8.

21.

Action potential dynamics explain arrhythmic vulnerability in human heart failure: a clinical and modeling study implicating abnormal calcium handling.

Narayan SM, Bayer JD, Lalani G, Trayanova NA.

J Am Coll Cardiol. 2008 Nov 25;52(22):1782-92. doi: 10.1016/j.jacc.2008.08.037.

22.

Laplace-Dirichlet energy field specification for deformable models. an FEM approach to active contour fitting.

Bayer JD, Beaumont J, Krol A.

Ann Biomed Eng. 2005 Sep;33(9):1175-86.

PMID:
16133925

Supplemental Content

Loading ...
Support Center